Kian Kani Lawrence J. Ellison Institute for Transformative Medicine, Center for Applied Molecular Medicine University of Southern California Biography Publications Institution JoVE Articles Kian Kani has not added a biography. If you are Kian Kani and would like to personalize this page please email our Author Liaison for assistance. Publications Identification, Characterization and Application of a New Peptide Against Anterior Gradient Homolog 2 (AGR2) Oncotarget. Jun, 2018 | Pubmed ID: 29937991 A Blood Biomarker for Monitoring Response to Anti-EGFR Therapy Cancer Biomarkers : Section A of Disease Markers. 2018 | Pubmed ID: 29689709 Protein Mimetic and Anticancer Properties of Monocyte-Targeting Peptide Amphiphile Micelles ACS Biomaterials Science & Engineering. Dec, 2017 | Pubmed ID: 29302619 JUN-Mediated Downregulation of EGFR Signaling Is Associated with Resistance to Gefitinib in EGFR-mutant NSCLC Cell Lines Molecular Cancer Therapeutics. Aug, 2017 | Pubmed ID: 28566434 Androgen Receptor in Cancer-associated Fibroblasts Influences Stemness in Cancer Cells Endocrine-related Cancer. 04, 2017 | Pubmed ID: 28264911 Quantitative Proteomics Using SILAC Methods in Molecular Biology (Clifton, N.J.). 2017 | Pubmed ID: 28188530 Simulation of the Protein-Shedding Kinetics of a Fully Vascularized Tumor Cancer Informatics. 2015 | Pubmed ID: 26715830 Anterior Gradient 2 (AGR2): Blood-based Biomarker Elevated in Metastatic Prostate Cancer Associated with the Neuroendocrine Phenotype The Prostate. Feb, 2013 | Pubmed ID: 22911164 Ein Plattformübergreifendes Toolkit Für Massenspektrometrie Und Proteomik Nature Biotechnology. Oct, 2012 | Pubmed ID: 23051804 Quantitative Proteomic Profiling Identifies Protein Correlates to EGFR Kinase Inhibition Molecular Cancer Therapeutics. May, 2012 | Pubmed ID: 22411897 Investigation of Acquired Resistance to EGFR-targeted Therapies in Lung Cancer Using CDNA Microarrays Methods in Molecular Biology (Clifton, N.J.). 2012 | Pubmed ID: 21960227 Impact of Protein Stability, Cellular Localization, and Abundance on Proteomic Detection of Tumor-derived Proteins in Plasma PloS One. 2011 | Pubmed ID: 21829587 Model-based Discovery of Circulating Biomarkers Methods in Molecular Biology (Clifton, N.J.). 2011 | Pubmed ID: 21468942 Beurteilung der Widerstandsfähigkeit gegen Tyrosin-Kinase-Inhibitoren durch eine Befragung von Signal Transduction Bahnen durch Antikörper-Arrays Katrin Tiemann1, Carolina Garri1, Jeffrey Wang1, Lauren Clarke1, Kian Kani1 1Lawrence J. Ellison Institute for Transformative Medicine, Center for Applied Molecular Medicine, University of Southern California JoVE 57779 암 연구학
Beurteilung der Widerstandsfähigkeit gegen Tyrosin-Kinase-Inhibitoren durch eine Befragung von Signal Transduction Bahnen durch Antikörper-Arrays Katrin Tiemann1, Carolina Garri1, Jeffrey Wang1, Lauren Clarke1, Kian Kani1 1Lawrence J. Ellison Institute for Transformative Medicine, Center for Applied Molecular Medicine, University of Southern California JoVE 57779 암 연구학